# OnCo record protagonist-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/protagonist-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "protagonist-therapeutics" ;
  schema:name "Protagonist Therapeutics"@en ;
  schema:alternateName "Protagonist Therapeutics, Inc."@en, "Protagonist"@en ;
  schema:description "Protagonist is a California peptide company whose hepcidin mimetic rusfertide controls the excess red cell production of polycythaemia vera without repeated phlebotomy, with positive phase 3 VERIFY results in 2025 and a partnership with Takeda."@en ;
  schema:url <https://onco.cc/companies/protagonist-therapeutics/>, <https://www.protagonist-inc.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.protagonist-inc.com>, <https://clinicaltrials.gov/search?lead=Protagonist%20Therapeutics> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/rusfertide/> ;
  onco:companies <https://onco.cc/companies/takeda/> ;
  onco:trials <https://onco.cc/trials/verify/>, <https://onco.cc/trials/nct06033586/> .